Literature DB >> 22016560

Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.

Huu Dat Tran1,2, Munirul Alam3, Nguyen Vu Trung1,2, Nguyen Van Kinh4,2, Hong Ha Nguyen2, Van Ca Pham2, Mohammad Ansaruzzaman3, Shah Manzur Rashed3, Nurul A Bhuiyan3, Tuyet Trinh Dao2, Hubert P Endtz5,3, Heiman F L Wertheim6,7.   

Abstract

Since 2007, there has been a re-emergence of cholera outbreaks in northern Vietnam. To understand the molecular epidemiological relatedness and determine the antibiotic susceptibility profiles of responsible V. cholerae O1 outbreak strains, a representative collection of 100 V. cholerae O1 strains was characterized. V. cholerae O1 strains isolated from diarrhoeal patients in northern Vietnam between 2007 and 2010 were investigated for antibiotic susceptibility and characterized by using phenotypic and genotypic tests, including PFGE analysis. Ten clinical V. cholerae O1 isolates from Bangladesh and Zimbabwe were included for comparison. The results revealed that all isolates were resistant to co-trimoxazole and nalidixic acid, 29 % were resistant to tetracycline and 1 % were resistant to azithromycin. All strains were susceptible to ampicillin-sulbactam, doxycycline, chloramphenicol and ciprofloxacin and 95 % were susceptible to azithromycin. MIC values did show reduced susceptibility to fluoroquinolones and 63 % of the strains were intermediately resistant to tetracycline. The isolates expressed phenotypic traits of both serogroup O1 Ogawa and El Tor and harboured an rstR El Tor and ctxB classical biotype. Among the outbreak isolates, only a single PFGE pattern was observed throughout the study period. This study shows that multi-drug resistant V. cholerae altered El Tor producing classical CT strains are now predominant in northern Vietnam.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22016560      PMCID: PMC3347965          DOI: 10.1099/jmm.0.034744-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


Introduction

Cholera is an acute diarrhoeal disease, causing profuse watery stools, which, if untreated, leads to rapid dehydration and death (Kaper ). Cholera is prevalent in developing countries with inadequate sanitation and poor access to safe drinking water (Zuckerman ). From 1995 to 2005, approximately 100 000–300 000 cases of cholera causing 1500 deaths were reported annually to the WHO (Griffith ). Cholera is caused by the Gram-negative bacterium Vibrio cholerae serogroups O1 and O139 (Kaper ). Serogroup O1 can be categorized into two biotypes (classical or El Tor), and three serotypes (Ogawa, Inaba or Hikojima) (Sack ). The seventh, and current, pandemic of cholera is being caused by the El Tor biotype while the fifth and sixth pandemics of cholera were caused by the classical biotype (Alam ). Recently, new variants of V. cholerae O1 have emerged and spread throughout many countries of Asia, Africa and America that display a mixture of phenotypic and genotypic traits of both classical and El Tor biotypes (Alam ; Ansaruzzaman ). Since the first variants of V. cholerae O1 El Tor were identified in Bangladesh, several other atypical El Tor strains have been identified and reported (Ansaruzzaman ; Choi ). Genotypic tests to differentiate V. cholerae O1 biotypes include ctxB (cholera toxin B), rstR (repeat sequence transcriptional) and tcpA (toxin-coregulated pili) gene typing (Safa ). The El Tor strains that cause cholera in many countries have shifted from genotype 3 (found in El Tor strains from the seventh pandemic and the Latin American epidemic) to genotype 1 (found in strains of classical biotype worldwide and US Gulf Coast El Tor strains). In addition, atypical El Tor strains of V. cholerae O1 from Asia and Africa harboured an rstR allele known as rstRClassical, which corresponds with CTXΦClassical and are reported as hybrid strains of the El Tor biotype (Ansaruzzaman ). Moreover, the multi-drug resistant V. cholerae O1 altered El Tor has emerged as major problem in many countries in Asia and Africa (Ang ; Jain ; Kumar ; Quilici ). In 2007, a cholera outbreak emerged in northern Vietnam, where only a few cases of cholera had previously been reported (Dalsgaard ). The strains of V. cholerae O1 responsible for this outbreak were variants of the El Tor biotype displaying combinations of classical and El Tor features (Nguyen ). New cholera cases continued to be detected in northern Vietnam until 2010, especially in Hanoi. The V. cholerae O1 strains associated with cholera outbreaks between 2007 and 2010 in northern Vietnam have not yet been characterized and their susceptibility to antimicrobials has not been reported. Moreover, there is lack of information about the genetic diversity among V. cholerae O1 strains isolated from patients in northern Vietnam between 2007 and 2010. In the present study, we investigated the antimicrobial susceptibilities and the molecular epidemiological traits of V. cholerae O1 strains isolated in northern Vietnam from 2007 to 2010. V. cholerae O1 strains from Bangladesh and Zimbabwe were also included for comparison.

Methods

Bacterial strains.

In this study, we combined two collections of V. cholerae O1 strains that were selected randomly from diarrhoeal patients admitted to the National Hospital for Tropical Diseases (NHTD), a tertiary-care hospital in Hanoi, Vietnam. The NHTD served as a referral centre during the cholera outbreaks in Hanoi and the surrounding areas between 2007 and 2010. Antimicrobial susceptibility testing was performed on 100 isolates from patients admitted in 2008. A second collection contained 100 randomly selected strains isolated from patients with acute diarrhoea who were admitted to the NHTD between 2007 and 2010 (25 isolates for each year). V. cholerae was identified and confirmed by using standard biochemical methods (Islam ). Serological identification of isolates was done by performing slide agglutination tests with commercially available polyvalent antiserum against V. cholerae O1 and monovalent antiserum against V. cholerae O1 serogroups Ogawa and Inaba (Bio-Rad) (Dalsgaard ). The second collection was shipped in soft agar at ambient temperature to the ICDDR,B for phenotypic and genotypic testing and PFGE analysis. Reference strains for each of the V. cholerae O1 biotypes were used: classical (O395) and El Tor (N16961). Ten clinical isolates each of V. cholera O1 from Bangladesh and Zimbabwe were included for comparison.

Serotyping and biotyping.

Vietnamese V. cholerae strains were serotyped by using the slide agglutination test with specific polyvalent antiserum to V. cholerae O1 and serotype specific antisera to Inaba and Ogawa from the ICDDR,B (Ansaruzzaman ). For biotype analysis, we used chicken erythrocyte agglutination, sensitivity to polymycin B and Mukerjee classical phage IV and Mukerjee El Tor phage 5 tests (Kaper ; Sack ).

PCR assays.

The characterization of biotype and genotype were performed with molecular methods. Species-specific identification of V. cholerae was carried out by using V. cholerae species-specific ompW PCR (Nandi ). The serogroups of these strains were reconfirmed by multiplex PCR targeted to identify genes encoding O1 (rfb) and O139 (rfb), specific O biosynthetic genes and the cholera toxin (CTX) gene (ctxA) (Hoshino ). Biotype specific characterizations were performed by using PCR assays targeted to detect tcpA (Classical and El Tor) (Keasler & Hall, 1993) and the type of the rstR (El Tor and Classical alleles) gene encoding the phage transcriptional regulator (Bhattacharya ). Mismatch amplification mutation assay (MAMA)-PCR to detect sequence polymorphism between the classical and El Tor ctxB gene was performed to distinguish the type of CTXB of the V. cholerae O1 strains included in this study (Morita ); primers and procedures were used as described previously (Alam ).

Antimicrobial susceptibility.

Antimicrobial susceptibility to ampicillin (AMP), ampicillin/sulbactam (AXS), nalidixic acid (NAL), ciprofloxacin (CIP), trimethoprim/sulfamethoxazole (SXT), chloramphenicol (CHL), tetracycline (TCY), levofloxacin (LVX), azithromycin (AZM), doxycycline (DOX) was determined using E-test strips (bioMérieux), according to the manufacturer’s instructions. Cut-off levels for assessing resistance were used according to CLSI document M45 guidelines (CLSI, 2010a). For nalidixic acid, the MIC break point for Enterobacteriaceae was used, as published in CLSI document M100 (CLSI, 2010b).

PFGE.

Intact agarose-embedded chromosomal DNA from 16 representative strains of V. cholerae O1 from Vietnam and four strains from Bangladesh and Zimbabwe was prepared and PFGE was performed using contour-clamped homogeneous electric field apparatus (Bio-Rad) according to the PulseNet procedure (Cooper ). Genomic DNA was digested with the NotI restriction enzyme (Gibco-BRL). The electrophoresis was performed by using CHEF-DRII system apparatus and conditions. Images were captured and converted to tif files for computer analysis (Nusrin ). Salmonella enterica serotype Braenderup strain H9812 was used as a molecular size marker.

Results

Serotyping and biotyping

Serogrouping and bio-typing of Vietnamese V. cholerae strains revealed that all the strains belonged to the serogroup O1 Ogawa and the biotype El Tor (Table 1). Slide agglutination tests with antisera showed that all strains were positive to polyvalent O1 and monovalent Ogawa. Biotyping showed that all strains were resistant to polymycin B 50 IU, agglutinated to chicken erythrocytes and were resistant to classical phage IV and sensitive to El Tor phage 5, which are typical traits of the El Tor biotype.
Table 1.

Characteristics of clinical isolates of V. cholerae O1

EL, El Tor type; CL, classical type; +, positive; −, negative.

Country/sourceSerotypeBiotypeGenotype by PCR
Chicken cell agglutinationPolymycin B 50 U sensitivityEl Tor phage 5Classical phage IVrstRtcpActxB
VietnamO1 Ogawa+ResistantSensitiveResistantELELCLompW+, rfbO1+, rfbO139, ctxA+
BangladeshO1 Ogawa+ResistantSensitiveResistantELELCLompW+, rfbO1+, rfbO139, ctxA+
ZimbabweO1 Ogawa+ResistantSensitiveResistantELELCLompW+, rfbO1+, rfbO139, ctxA+
N16961 El Tor referenceO1 Inaba+ResistantSensitiveResistantELELELompW+, rfbO1+, rfbO139, ctxA+
O395 classical referenceO1 OgawaSensitiveResistantSensitiveCLCLCLompW+, rfbO1+, rfbO139, ctxA+

Characteristics of clinical isolates of V. cholerae O1

EL, El Tor type; CL, classical type; +, positive; −, negative.

PCR assays

Examination of genotypic traits also confirmed that the Vietnamese V. cholerae were of the O1 serogroup and altered El Tor variant (Table 1). PCRs for the V. cholerae species-specific gene ompW and serogroup-specific gene rfbO1 were positive for all strains. All strains harboured rstREl and tcpA genes which are specific to strains of the El Tor biotype. Results of MAMA-PCR showed that all the V. cholerae isolates from Vietnam in this study harboured the ctxB1 allele which had been identified in strains of the classical biotype worldwide and in US Gulf Coast El Tor strains. All strains were positive for the ctxA gene.

Antimicrobial susceptibility

The percentages of the isolates that were susceptible, intermediately resistant or resistant to each microbial agent as well as the mean and range of MIC values are presented in Table 2. The data revealed that the isolates were susceptible to amipicillin (98 %), ampicillin/sulbactam (100 %), doxycycline (100 %), chloramphenicol (100 %), ciprofloxacin (100 %), levofloxacin (100 %), and azithromycin (95 %). However, the isolates exhibited high rate of resistance to trimethoprim/sulfamethoxazole (100 %), nalidixic acid (100 %) and tetracycline (29 %). In addition, most isolates were intermediately resistant to tetracycline (63 %).
Table 2.

Antimicrobial susceptibility profile of V. cholerae O1 strains using the E-test method

All MIC values are given in µg ml−1. nd, Not determined.

Antimicrobial(s)No. strainsResistance pattern Mean MICvaluesRange of MIC values
SensitiveIntermediately resistantResistantMIC50MIC90
Percentage of strains testedMICPercentage of strains testedMICPercentage of strains testedMIC
Ampicillin10098≤82160≥32361–12
Ampicillin/sulbactam (2/1)92100≤8/4016/80≥32/1633<8/4
Tetracycline1008≤463829≥168121–24
Doxycycline97100≤4080≥16220.25–3
Trimethoprim/sulfamethoxazole (1/19)1000≤2/380nd100≥4/763232>4/76
Chloramphenicol100100≤80160≥320.50.750.38–1
Ciprofloxacin100100≤1020≥40.380.50.125–0.75
Levofloxacin100100≤2040≥80.380.50.125–0.75
Nalidixic acid*1000≤160nd100≥32256256256–256
Azithromycin10095≤2441≥81.520.25–32

MIC interpretive standard for Enterobacteriaceae.

Antimicrobial susceptibility profile of V. cholerae O1 strains using the E-test method

All MIC values are given in µg ml−1. nd, Not determined. MIC interpretive standard for Enterobacteriaceae. There were four resistance patterns (Table 3) among the 100 strains tested. The most prevalent pattern was a resistance to nalidixic acid, co-trimoxazole and tetracycline (including cases of intermediate resistance).
Table 3.

Antibiotic resistance profiles of both intermediately resistant and resistant V. cholerae O1 isolates

AMP, ampicillin; AXS, ampicillin/sulbactam; NAL, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim/sulfamethoxazole; CHL, chloramphenicol; TCY, tetracycline; LVX, levofloxacin; AZM, azithromycin, DOX, doxycycline.

TypeAntibiotic resistance profileNo. strains
INAL, SXT8
IINAL, SXT, TCY85
IIIAZM, NAL, SXT, TCY5
IVAMP, NAL, SXT, TCY2
Total100

Antibiotic resistance profiles of both intermediately resistant and resistant V. cholerae O1 isolates

AMP, ampicillin; AXS, ampicillin/sulbactam; NAL, nalidixic acid; CIP, ciprofloxacin; SXT, trimethoprim/sulfamethoxazole; CHL, chloramphenicol; TCY, tetracycline; LVX, levofloxacin; AZM, azithromycin, DOX, doxycycline.

PFGE

In the present study, PFGE analysis of the representative Vietnamese strains isolated between 2007 and 2010 showed an indistinguishable PFGE banding pattern that was typical of V. cholerae O1 El Tor (Fig. 1). The NotI restriction enzyme cleaved the chromosomal genome into 18 fragments with fragment sizes ranging from 20 to 398 kb. The PFGE patterns of isolates from Bangladesh and Zimbabwe differed slightly from the Vietnamese strains by a single band position, suggesting genetic divergence (Fig. 1).
Fig. 1.

NotI-restricted PFGE profiles of V. cholerae O1 strains isolated from Vietnam, Zimbabwe and Bangladesh. Vietnamese strains are indicated with a V-number, PCS-12 and PCS34 are Bangladesh strains and Z-47(2009) and Z-62(2009) are Zimbabwe strains. SB, Salmonella Braenderup molecular size marker.

NotI-restricted PFGE profiles of V. cholerae O1 strains isolated from Vietnam, Zimbabwe and Bangladesh. Vietnamese strains are indicated with a V-number, PCS-12 and PCS34 are Bangladesh strains and Z-47(2009) and Z-62(2009) are Zimbabwe strains. SB, Salmonella Braenderup molecular size marker. When cluster analysis was performed to produce dendrograms, prepared using the Dice similarity coefficient and unweighted pair group method with arithmetic mean (UPGMA) clustering, using the PFGE patterns, all the El Tor strains shared a major cluster (Fig. 2) in which all the Vietnamese strains shared 100 % similarity, whereas the Bangladesh and Zimbabwe strains formed another closely related cluster showing 98 % similarity to the Vietnamese strains.
Fig. 2.

NotI-restricted PFGE profiles and a dendrogram reconstructed using UPGMA based on the banding patterns of V. cholerae O1 strains from Vietnam, Zimbabwe and Bangladesh. Cluster a includes all the Vietnamese strains showing 100 % similarity. Cluster b includes strains from Zimbabwe (Z-47 and Z-62) and Bangladesh (PCS-12 and PCS-34).

NotI-restricted PFGE profiles and a dendrogram reconstructed using UPGMA based on the banding patterns of V. cholerae O1 strains from Vietnam, Zimbabwe and Bangladesh. Cluster a includes all the Vietnamese strains showing 100 % similarity. Cluster b includes strains from Zimbabwe (Z-47 and Z-62) and Bangladesh (PCS-12 and PCS-34). The PFGE (Fig. 1) results also indicate that the altered strains from Vietnam are more closely related to the El Tor reference strain (N16961) than to the classical reference strain (O395).

Discussion

According to the new biotyping scheme proposed for V. cholerae O1 (Raychoudhuri ), the results show that the Vietnamese V. cholerae O1 strains are variant El Tor strains. The strains have phenotypic traits of the El Tor biotype and genotypic traits of both El Tor and classical biotypes (rstREl/ctxB1). These variant strains were first reported in Bangladesh (Nair , 2006). The emergence and spread of a new variant of V. cholerae O1 urges the redefinition of V. cholerae classification (Raychoudhuri ; Safa ). Recently, a new biotyping scheme was proposed, using the molecular marker genes ctxB, rtxC, tlc, tcpA and RS element, which added a further two biotypes, designated ‘hybrid’ and ‘El Tor variant’, to the classification of newly emerging V. cholerae O1 strains (Raychoudhuri ). Earlier work already showed that cholera outbreaks in northern Vietnam in 2007 and early 2008 were caused by a V. cholerae O1 El Tor variant biotype strain producing ‘classical’ CTXB. This El Tor variant strain was probably imported into northern Vietnam around 2007 and subsequently replaced the endemic strains which contained a tandem repeat of the classical CTX prophage on the small chromosome, similar to the Mozambican variant, and were responsible for small cholera outbreaks before 2007 in Vietnam (Nguyen ). Our genotyping data reveal that cholera outbreaks in northern Vietnam between 2007 and 2010 were caused by a single clone, confirming that the new V. cholerae O1 El Tor variant strain is predominant and has replaced the traditional El Tor biotype. It is currently known that all the V. cholerae O1 strains isolated in Bangladesh after 2001 were atypical or El Tor variant strains as they were phenotypically and genetically similar to El Tor but had the ctxB1 gene of the classical biotype (Nair , 2006). Subsequent studies reported such variant strains in Mozambique (Ansaruzzaman ), Vietnam (Nguyen ), Zimbabwe (this study) and Mexico (Alam ). Although the Vietnamese V. cholerae strains isolated between 2007 and 2010 were of the El Tor variant biotype and had PFGE patterns closely related to those of V. cholerae strains isolated from contemporary cholera outbreaks in Zimbabwe and Bangladesh, they had minor but consistent divergences, suggesting that the Vietnamese strains had an independent lineage and occupied a local niche. Using multi-locus variable number tandem repeat analysis, a recent study demonstrated that altered strains from Vietnam are distant from the El Tor prototype strain responsible for the seventh cholera pandemic (Choi ). In spite of the minor divergences observed in the present study, the Vietnamese V. cholerae O1 strains with the RS1–CTX prophage (El Tor type rstR and classical ctxB) array on the large chromosome is likely to be more closely related to V. cholerae O1 El Tor variant strains currently circulating in Bangladesh (Nair ), India (Goel ) and Thailand (Okada ). However, our data are insufficient to verify the source of the V. cholerae O1 strains currently circulating in Vietnam. Most of the strains from Vietnam were multi-drug resistant with common resistance to nalidixic acid, co-trimoxazole and tetracycline. All isolates were susceptible to doxycycline. Resistance to tetracycline, a common antimicrobial agent for the treatment of cholera (WHO, 2005), was also high (29 %). Both tetracycline and doxycycline belong to the tetracycline antibiotic group and cross-resistance between these agents exists (Fluit ). The use of doxycycline for cholera treatment and the trend of V. cholerae O1 resistance to the tetracycline group of antibiotics should be monitored. All isolates were resistant to co-trimoxazole, a recommended first-line agent for children with diarrhoea. A high incidence of co-trimoxazole resistance in V. cholerae O1 strains has been reported in prior studies in Africa, Asia and South America (Goel & Jiang, 2010; Ibarra & Alvarado, 2007; Mandomando ). In Vietnam, there is also an increase in resistance to co-trimoxazole among diarrhoeagenic strains of E. coli and Shigella isolated from children in Hanoi (Nguyen ). This indicates that co-trimoxazole should not be the recommended treatment for children with diarrhoea in Vietnam. All the O1 V. cholerae strains were susceptible to fluoroquinolones, including ciprofloxacin and levofloxacin. However, the MIC90 of ciprofloxacin was close to the susceptibility breakpoint of 1 mg l−1. All the V. cholerae O1 strains from Vietnam were completely resistant to nalidixic acid (MIC 256 µg ml−1). V. cholerae O1 strains resistant to fluoroquinolones have been reported from India (Krishna ). The high incidence of nalidixic acid resistance in V. cholerae O1 and increased resistance of V. cholerae against ciprofloxacin is cause for concern (Islam ). Although the MICs of ciprofloxacin for the Vietnamese V. cholerae O1 strains were still below the susceptibility breakpoint, they had increased compared to historical isolates; this may be an indication of the emergence of high-level fluoroquinolone resistance in the near future. The majority of the Vietnamese strains (95 %) were still susceptible to azithromycin and this antibiotic can still be used for treatment in Vietnam, though further development of resistance needs to be monitored. Azithromycin is used for treatment of diarrhoeal diseases worldwide (de Saussure, 2009) and has shown to be effective in treatment of cholera in children and adults (Saha ). In general, the Vietnamese V. cholerae strains showed similar resistance patterns to Indian and Thai strains of the altered V. cholerae O1 El Tor biotype, carrying the classical ctxB allele; a new variant of V. cholerae O1 (Jain ; Okada ).

Conclusion

Between 2007 and 2010, cholera outbreaks in Vietnam have been caused by a single clone of a variant V. cholerae O1 biotype El Tor strain. This variant was closely linked to similar variants of V. cholerae O1 El Tor strains isolated in Bangladesh and Zimbabwe but had a slightly divergent lineage, suggesting that they have evolved in solitary and independent ecosystem. A significant proportion of strains were multi-drug resistant, although the majority were still borderline susceptible to fluoroquinolones and susceptible to azithromycin. Empirical treatment of cholera with fluoroquinolones needs to be reconsidered.
  36 in total

1.  Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B.

Authors:  Seon Young Choi; Je Hee Lee; Yoon-Seong Jeon; Hye Ri Lee; Eun Jin Kim; M Ansaruzzaman; Nurul A Bhuiyan; Hubert P Endtz; S K Niyogi; B L Sarkar; G Balakrish Nair; Binh Minh Nguyen; Nguyen Tran Hien; Cecil Czerkinsky; John D Clemens; Jongsik Chun; Dong Wook Kim
Journal:  J Med Microbiol       Date:  2010-03-18       Impact factor: 2.472

2.  Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.

Authors:  Ad C Fluit; Alice Florijn; Jan Verhoef; Dana Milatovic
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe.

Authors:  M Sirajul Islam; Stanley M Midzi; Lincoln Charimari; Alejandro Cravioto; Hubert P Endtz
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

4.  Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.

Authors:  B V S Krishna; Asha B Patil; M R Chandrasekhar
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10-24       Impact factor: 2.184

5.  Multidrug resistant Vibrio cholerae O1 El Tor carrying classical ctxB allele involved in a cholera outbreak in South Western India.

Authors:  M Jain; A K Goel; P Bhattacharya; M Ghatole; D V Kamboj
Journal:  Acta Trop       Date:  2010-12-11       Impact factor: 3.112

6.  Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.

Authors:  Trung Vu Nguyen; Phung Van Le; Chinh Huy Le; Andrej Weintraub
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 7.  Cholera.

Authors:  David A Sack; R Bradley Sack; G Balakrish Nair; A K Siddique
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

8.  Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor.

Authors:  Masatomo Morita; Makoto Ohnishi; Eiji Arakawa; N A Bhuiyan; Suraia Nusrin; Munirul Alam; A K Siddique; Firdausi Qadri; Hidemasa Izumiya; G Balakrish Nair; Haruo Watanabe
Journal:  Microbiol Immunol       Date:  2008-06       Impact factor: 1.955

9.  Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique.

Authors:  Inácio Mandomando; Mateu Espasa; Xavier Vallès; Jahit Sacarlal; Betuel Sigaúque; Joaquim Ruiz; Pedro Alonso
Journal:  J Antimicrob Chemother       Date:  2007-07-11       Impact factor: 5.790

10.  Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.

Authors:  Marie Laure Quilici; Denis Massenet; Bouba Gake; Barem Bwalki; David M Olson
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

View more
  17 in total

1.  Emergence of multidrug-resistant Vibrio cholerae O1 biotype El Tor in Port Blair, India.

Authors:  Debdutta Bhattacharya; D S Sayi; R Thamizhmani; Haimanti Bhattacharjee; A P Bharadwaj; Avijit Roy; A P Sugunan
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  The seventh pandemic Vibrio cholerae O1 El Tor isolate in China has undergone genetic shifts.

Authors:  Ping Zhang; Fengjuan Li; Weili Liang; Jie Li; Biao Kan; Duochun Wang
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

3.  Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.

Authors:  Chariya Chomvarin; Fatema-Tuz Johura; Shahnewaj B Mannan; Warin Jumroenjit; Boonnapa Kanoktippornchai; Waraluk Tangkanakul; Napaporn Tantisuwichwong; Sriwanna Huttayananont; Haruo Watanabe; Nur A Hasan; Anwar Huq; Alejandro Cravioto; Rita R Colwell; Munirul Alam
Journal:  J Med Microbiol       Date:  2013-01-14       Impact factor: 2.472

4.  Surveillance of Bacterial Pathogens of Diarrhoea in Two Selected Sub Metros Within the Accra Metropolis.

Authors:  E K Dzotsi; A Z Dongdem; G Boateng; L Antwi; G Owusu-Okyere; D B Nartey; M Olu-Taiwo; M J Adjabeng; J Amankwa; B Sarkodie; J Addo; E Antwi; E Aryee; J A Opintan
Journal:  Ghana Med J       Date:  2015-06

5.  Genetic relatedness of selected clinical Vibrio cholerae O139 isolates from the southern coastal area of China over a 20-year period.

Authors:  B S Li; Y Xiao; D C Wang; H L Tan; B X Ke; D M He; C W Ke; Y H Zhang
Journal:  Epidemiol Infect       Date:  2016-06-16       Impact factor: 4.434

6.  Outbreak-associated Vibrio cholerae genotypes with identical pulsotypes, Malaysia, 2009.

Authors:  Cindy Shuan Ju Teh; Zarizal Suhaili; King Ting Lim; Muhamad Afif Khamaruddin; Fariha Yahya; Mohd Hailmi Sajili; Chew Chieng Yeo; Kwai Lin Thong
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

7.  Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro.

Authors:  M Shamim Hasan Zahid; Sharda Prasad Awasthi; Atsushi Hinenoya; Shinji Yamasaki
Journal:  J Vet Med Sci       Date:  2015-01-19       Impact factor: 1.267

8.  Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds.

Authors:  Debmalya Barh; Neha Barve; Krishnakant Gupta; Sudha Chandra; Neha Jain; Sandeep Tiwari; Nidia Leon-Sicairos; Adrian Canizalez-Roman; Anderson Rodrigues dos Santos; Syed Shah Hassan; Síntia Almeida; Rommel Thiago Jucá Ramos; Vinicius Augusto Carvalho de Abreu; Adriana Ribeiro Carneiro; Siomar de Castro Soares; Thiago Luiz de Paula Castro; Anderson Miyoshi; Artur Silva; Anil Kumar; Amarendra Narayan Misra; Kenneth Blum; Eric R Braverman; Vasco Azevedo
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Size-dependent antimicrobial effects of novel palladium nanoparticles.

Authors:  Clara P Adams; Katherine A Walker; Sherine O Obare; Kathryn M Docherty
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

10.  Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.

Authors:  Kinh Van Nguyen; Nga Thuy Thi Do; Arjun Chandna; Trung Vu Nguyen; Ca Van Pham; Phuong Mai Doan; An Quoc Nguyen; Chuc Kim Thi Nguyen; Mattias Larsson; Socorro Escalante; Babatunde Olowokure; Ramanan Laxminarayan; Hellen Gelband; Peter Horby; Ha Bich Thi Ngo; Mai Thanh Hoang; Jeremy Farrar; Tran Tinh Hien; Heiman F L Wertheim
Journal:  BMC Public Health       Date:  2013-12-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.